In this regard, emerging self-assembly pH-sensitive pegylated nano drug delivery systems, namely HA-mPEG-Cis NPs, are able to target CD44-CRC-positive cells and dissolve the hydrated PEG in the acidic tumor environment. The gene discussed is CD44; the disease is colorectal carcinoma.